Simvastatin improves mitochondrial respiration in peripheral blood cells

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Statins treat hypercholesterolemia but can cause myalgia, leading to treatment discontinuation.
• Statin-Associated Myopathy (SAM) is linked to mitochondrial dysfunction, but the exact mechanism is unclear.

Purpose of the Study:

• To investigate the effects of long-term Simvastatin treatment on mitochondrial function and superoxide production in hypercholesterolemic patients.
• To explore the potential of ubiquinone (coenzyme Q10) as a treatment for SAM.

Main Methods:

• Measured mitochondrial respiration and superoxide levels in peripheral blood mononuclear cells (PBMCs) and platelets from Simvastatin-treated and untreated patients.
• Assessed the impact of an 8-week ubiquinone supplementation on these mitochondrial parameters.

Main Results:

• Long-term Simvastatin use significantly increased mitochondrial respiration and superoxide production in PBMCs and platelets.
• Increased mitochondrial superoxide, but not respiration, correlated with patient-reported myalgia.
• Ubiquinone supplementation did not alter mitochondrial function or superoxide levels in treated patients.

Conclusions:

• Long-term Simvastatin therapy enhances mitochondrial respiration and superoxide production, potentially contributing to SAM.
• Ubiquinone is ineffective in treating SAM by improving mitochondrial function or reducing superoxide.
• Further research is needed to understand and manage statin-induced myopathy.